Anhui Jinhe Pharmaceutical

Anhui Jinhe Pharmaceutical is a specialized subsidiary of Anhui Jinhe Industrial Co., Ltd., a leading Chinese chemical and food additive manufacturer listed on the Shenzhen Stock Exchange. The company focuses on the research, development, and large-scale production of high-purity active pharmaceutical ingredients (APIs) and advanced pharmaceutical intermediates. Its core product portfolio includes crisaborole, a non-steroidal PDE4 inhibitor used for treating atopic dermatitis, and sinomenine hydrochloride, an alkaloid used for inflammatory conditions like rheumatoid arthritis. Leveraging the extensive manufacturing infrastructure and chemical synthesis expertise of its parent company, Anhui Jinhe Pharmaceutical serves a global clientele in the dermatology and specialty therapeutic sectors. The company operates with a strong emphasis on regulatory compliance and high-quality manufacturing standards to meet international pharmaceutical requirements.